CD274 and lung cancer: It has to be noted, however, that IHC scoring is already part of the diagnostic standard work-up in several tumors, including breast, brain, and lung cancers, e.g., in the latter to quantify PD1/PD-L1 expression to guide checkpoint inhibitor therapy48.